The Institute of Neurology and Neurosurgery (INN) at Saint Barnabas prides itself in its involvement in the demanding world of neurological research for over 20 years. The INN conducts research associated with a variety of neurological disorders with a particular focus in adult and childhood epilepsies, as well as studies in autism spectrum disorder and dementia. Investigational drug and product studies are constantly being conducted to bring new and improved anti-epileptic drugs to the market. The following drugs are currently being investigated by our research team:
Open to Enrollment:
- Adults with Focal-onset Epilepsy.
ClinicalTrials.gov Identifier: NCT03796962
- Ganaxolone Trial to treat Tuberous Sclerosis Complex-related epilepsy.
ClinicalTrials.gov Identifier: NCT04285346
- Dravet Syndrome.
ClinicalTrials.gov Identifier: NCT04572243
On-going trials -Enrollment closed:
- Ganaxolone trial to treat CDKL5 deficiency disorder.
ClinicalTrials.gov Identifier: NCT03572933
- ZX008-1900- An Extension trial for participants completed LGS and Dravet studies.
If you are interested in participating or learning more about our research please contact Munazza Malik, MD – Phone: 973-322-7425..